Prostate cancer is the most common cancer in men and is projected to become the most common cancer overall by 2030. In the UK, more than 44,000 men are diagnosed with the disease each year and it is estimated that there are more than 330,000 men living with prostate cancer.
Treatment options for prostate cancer vary depending on disease stage and patient choice and commonly include active surveillance, surgery, radiotherapy, hormone therapy and chemotherapy.
Fatigue and prostate cancer
Fatigue is a prevalent symptom in men with prostate cancer, especially following treatment, but it is poorly understood and is often not acknowledged at all in a man’s prostate cancer journey.
There also appears to be a significant discrepancy between the numbers of self-reported fatigue cases by men, compared to estimated figures by GPs, which suggests that many men experiencing fatigue may be falling through the net with little or no support in managing the condition.